Oculus Innovative Sciences, Inc. Share Price Nasdaq
Equities
US67575P2074
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-09 | Sonoma Pharmaceuticals, Inc. Announces New Distributor in Ukraine | CI |
06-17 | Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Sales 2025 * | 16.98M 1.31B | Sales 2026 * | 21.3M 1.64B | Capitalization | 8.11M 624M |
---|---|---|---|---|---|
Net income 2025 * | -3M -231M | Net income 2026 * | -1M -76.88M | EV / Sales 2025 * | 0.48 x |
Net cash position 2025 * | - 0 | Net cash position 2026 * | - 0 | EV / Sales 2026 * | 0.38 x |
P/E ratio 2025 * |
-2.13
x | P/E ratio 2026 * |
-4.74
x | Employees | - |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 97.88% |
Managers | Title | Age | Since |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 26/09/19 |
John Poggetto
DFI | Director of Finance/CFO | 72 | 31/12/01 |
Jerome Dvonch
DFI | Director of Finance/CFO | 56 | 07/09/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Amy Trombly
CEO | Chief Executive Officer | 57 | 26/09/19 |
Jay Birnbaum
BRD | Director/Board Member | 79 | 19/04/07 |
Director/Board Member | 64 | 18/09/18 |
1st Jan change | Capi. | |
---|---|---|
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |